PRN: Regulatory 'Guidance' and the Changes That Will Occur Surrounding Social Media in Pharmaceuticals
Regulatory 'Guidance' and the Changes That Will Occur Surrounding Social Media in Pharmaceuticals
LONDON, January 10, 2012 /PRNewswire/ --
SMi 3rdÂ annual conference on.....
Insight, strategy and imagination in successfully harnessing digital and social media
24th - 25th January 2012, Copthorne Tara Hotel, London
SMi's 3rd annual Social Media in the Pharmaceutical Industry conference, the premier event of its kind in Europe and the only event to focus exclusively on how social media can be used within the pharmaceutical industry and healthcare.
At this event you will hear about the regulatory 'guidance' and the changes that will occur surrounding social media in pharmaceuticals, case studies from big pharma companies, Alex Butler's input on the impact of social media in pharmaceuticals and what action needs to be taken to foster patient-doctor interaction.
Our key presenters include:
Andrew Widger, Director, Media Relations, EMEA, Pfizer
For more information visitÂ http://www.smi-online.co.uk/pharma-socialmedia76.aspÂ